Skip to main content

Pelvic inflammatory disease, intrauterine contraception, and the conduct of epidemiologic studies

Advances in Contraception volume 1, pages 63–76 (1985)Cite this article

Abstract

Pelvic inflammatory disease (PID) has been described in the medical literature for more than a century as a specific entity.Neisseria gonorrhoeae, Chlamydia trachomatis, andMycoplasma hominis, along withBacteroides fragilis and other anaerobic bacteria, have been most frequently associated with PID. Factors affecting the occurrence of PID have been extensively studied during the past two decades and include number of sexual partners, age, race, socioeconomic status, education, and contraceptive method. As knowledge concerning factors that contribute to PID increases, epidemiologic studies addressing such issues must become increasingly sophisticated, and the literature needs to be re-evaluated in light of present knowledge. Various risk factors for PID, types of epidemiologic studies, methods for conducting such studies, and data interpretation are reviewed.

Resumé

Il y a plus d'un siècle que la salpingite aiguë est décrite comme une entité spécifique dans la littérature médicale. Elle est généralement due àNeisseria gonorrhoeae, Chlamydia trachomatis etMycoplasma hominis, ainsi qu'àBacteroides fragilis et à d'autres bactéries anaérobies. Des études approfondies ont été conduites au cours des 2 dernières décennies, à propos des facteurs favorisant les salpingites: il s'agit notamment du nombre de partenaires sexuels, de l'âge, de la race, du niveau socio-économique, de l'éducation et des méthodes contraceptives. Plus notre connaissance des facteurs favorisant les salpingites s'améliore, et plus les études épidémiologiques concernant ces questions doivent être sophistiquées. En outre, il convient de revoir la littérature à la lumière des connaissances actuelles. On décrit divers facteurs de risque de salpingite, les types d'études épidémiologiques, les méthodes adoptées pour conduire ces études et l'interprétation de leurs résultats.

Resumen

La enfermedad inflamatoria pelviana (PID) ha sido descripta en la literatura médica durante mas de un siglo como una entidad separada.Neisseria gonorrhoeae, Chlamydia trachomatis, yMycoplasma hominis, junto conBacteroides fragilis y otras bacterias anaerobias, han sido mas frecuentemente asociadas con la inflamación pelviana. Durante las 2 últimas decadas se han estudiado extensamente los factores que afectan la ocurrencia de la inflamación pelviana e incluyen el número de contactos sexuales, edad, raza, nivel socioeconómico, educación y métodos contraceptivos. Como el conocimiento concerniente a factores que contribuyen a la inflamación pelviana está en aumento, los estudios epidemiológicos referentes a tales, deben volverse progresivamente más sofisticados y la literature necesita ser reevaluada a la luz de los conocimientos actuales. Se consideran varios factores de riesgo para la inflamación pelviana, tipos de estudios epidemiológicos, méthodos para conducir tales estudios e interpretación de datos.

This is a preview of subscription content, access via your institution.

References

  1. RubinA. (1955). Microwave therapy of chronic pelvic inflammatory disease.Obstet. Gynecol.,5, 157–159

    PubMed  Google Scholar 

  2. KellyH. (1898).Operative Gynecology, Vol. II, Appleton, New York, pp. 199, 212, 374, 412, 432–433

    Google Scholar 

  3. BrunetW. M. and SalbergJ. B. (1938). Fregnancy complicated by gonococcic salpingitis,Am. J. Obstet. Gynecol.,35, 1056–1057

    Google Scholar 

  4. KriogE. G. (1941). Clinical experience in the treatment of pelvic inflammatory disease with intradermal injections ofBacillus coli vaccine.Am. J. Obstet. Gynecol.,41, 105

    Google Scholar 

  5. KriegE. G. (1942). The treatment of pelvic inflammatory disease with intradermal administration ofBacillus coli vaccine.Am. J. Obstet. Gynecol.,44, 631

    Google Scholar 

  6. MårdhP. A., LindL., SvenssonL., WeströmL. and MellerB. R. (1981). Antibodies toChlamydia trachomatis, Mycopiasma hominis, andNeisseria gonorrhosae in sera from patients with acute salpingitis.Br. J. Vener. Dis.,57, 125–129

    PubMed  Google Scholar 

  7. SchachterJ. (1982). Sexually transmittedChlamydia trachomatis infection.Postgrad. Med.,72, 60–69

    PubMed  Google Scholar 

  8. SchachterJ., StenerE. and MoncadaJ. (1983). Screening for chlamydial infestions in women attending family planning clinics: evaluation of presumptive indicators for therapy.West. J. Med.,138, 375–379

    PubMed  Google Scholar 

  9. SweetR., SchachterJ. and RobbieM. (1982). Acute salpingitis; role of Chlamydia in the United States. In.Chlamydial Infections, Elsevier, New York, pp. 175–178

    Google Scholar 

  10. MøllerB. R. (1983). The role of Mycoplasma in the upper genital tracts of women.Sex. Transmiss. Dis.,10S, 28–288

    Google Scholar 

  11. MøllerB. R., MardhP., AhrensS. and NusslerE. (1981). Infection withChlamydia trachomatis, Mycoplasma hominis andNeisseria gonorrhoeae in patients with acute pelvic inflammatory disease.Sex. Transmiss. Dis.,8, 198–202

    Google Scholar 

  12. PaavonenJ., MiettinenA., StevensC. E., ChenK. C. S. and HolmesK. K. (1983).Mycoplasma hominis in nonspecific vaginitis,Sex. Transmiss. Dis.,10S, 271

    Google Scholar 

  13. CarterR., JonesC. P., AlterR. L., CreadickR. N. and ThomasW. L. (1953).Bacteroides infections in obstetrics and gynecology.Obstet. Gynecal.,3, 491

    Google Scholar 

  14. PaavonenJ., ValtonenV. V., KasperD. L., MalkamakiM. and MakelaP. H. (1981). Seriological evidence for the role ofBacteroides fragilis and enterobacteriaceae in the pathogenesis of acute pelvic inflammatory disease.Lancet,2, 293–295

    PubMed  Google Scholar 

  15. SweetR. L. (1981). Treatment of mixed aerobic-anaerobic infections of the female genital tract.J. Antimicrobial Chemother.,8, 105–114

    Google Scholar 

  16. PritschH. O., HofstatterA. and LindnerK. (1910). Experimentelle Studien zur Trachomfrage,v.Graefe's Arch. Ophthalmol.,76, 547

    Google Scholar 

  17. HalberstaedterL. and VonProwazekS. (1907). Ueber chlamyozoenbefunde bei Blennorhae neionatorum non gonorrhoica.Arb. Gesund. Amte.,26, 44–47

    Google Scholar 

  18. HareM. J. and ThinR. N. (1983). Chlamydial infection of the lower genital tract of women.Br. Med. Bull.,39, 138–144

    PubMed  Google Scholar 

  19. HeymannB. (1910). Uber die Fundorte der Prowazek'shen Korperchen.Berliner Klin. Wochenschr,47, 663–666

    Google Scholar 

  20. SchachterJ. and DawsonC. R. (1978). Genital tract infections. In:Human Chlamydial Infections, PSG, Inc., Littleton, MA, pp. 121–139

    Google Scholar 

  21. DienesL. and EdsallG. (1937). Observations on the L-Organism of Klieneberger.Prac. Soc. Exp. Biol. Med.,36, 740–744

    Google Scholar 

  22. FreundtE. A. (1983).Mycoplasma hominis: historical outline and taxonomy.Sex. Transmiss. Dis.,10(4), 226–229S

    Google Scholar 

  23. FreundtE. A. (1958).The Mycoplasmataceae (The Pleuropneumonia Group of Organisms): Morphology, Biology and Taxonomy, Munksgaard, Copenhagen

    Google Scholar 

  24. LemckeR. and CsonkaG. W. (1962). Antibodies against pleuropneumonia-like organisms in patients with salpingitis.Br. J. Vener. Dis.,38, 212–217

    PubMed  Google Scholar 

  25. MårdhP. A. and WeströmL. (1970). Tubal and cervical cultures in acute salpingitis with special reference toMycoplasma hominis and T-strain mycoplasmas.Br. J. Vener. Dis.,46, 179–186

    PubMed  Google Scholar 

  26. MelenB. and GotthardsonA. (1955). Complement fixation with human pleuropneumonia-like organisms.Acta. Pathol. Microbiol. Scand.,37, 196–200

    PubMed  Google Scholar 

  27. MeittinenA., PaavonenJ., JanssonE. and LeinikkiP. (1983). Enzyme immunoassay for serum antibody toMycoplasma hominis in women with acute pelvic inflammatory disease.Sex. Transmiss. Dis.,10S, 289–293

    Google Scholar 

  28. StemmerVonW. (1981). Uber die Ursachen von Einleiterentzundungen (On the cause of the introduction of inflammation).Zentralbl. Gynak.,22, 1061

    Google Scholar 

  29. HedbergE. and SpetzS. (1958). Acute salpingitis.Acta Obstet. Gynecol. Scand.,37, 131

    PubMed  Google Scholar 

  30. KeithL. G., BergerG. S., EdelmanG. A., NewtonW., FullanN., BaileyR. and FribergJ. (1984). On the causation of pelvic inflammatory disease.Am. J. Obstet. Gynecol.,149, 215–224

    PubMed  Google Scholar 

  31. BurkmanR. T. (1980). Intrauterine device use and the risk of pelvic inflammatory disease.Am. J. Obstet. Gynecol.,36, 452–454

    Google Scholar 

  32. FleshG., WeinerJ. M., CorlettR. C., BoiceC., MishellD. R. and WolfR. M. (1979). The intrauterine contraceptive device and acute salpingitis.Am. J. Obstet. Gynecol.,135, 402–408

    PubMed  Google Scholar 

  33. McCormackW. M. (1983). Epidemiology ofMycoplasma hominis.Sex. Transmiss. Dis.,10S, 261–262

    Google Scholar 

  34. StadelB. V. and SchlesselmanS. (1984). Extent of surgery for pelvic inflammatory disease in relation to duration of intrauterine device use.Obstet. Gynecol.,63, 171–178

    PubMed  Google Scholar 

  35. WeströmL. and MårdhP. A. (1982). Pelvic inflammatory disease: epidemiology, diagnosis, clinical manifestations, and sequelae. In:International Perspectives on Neglected Sexually Transmitted Diseases, K. K.Holmes and P. A.Mårdh, eds., Hemisphere Publishing Co., New York, pp. 235–250

    Google Scholar 

  36. WeströmL. (1983). Clinical manifestations and diagnosis of pelvic inflammatory disease.J. Reprod. Med.,28, 703–708S

    PubMed  Google Scholar 

  37. BoothM. and BeralV. (1980). Effect of age on pelvic inflammatory disease in nulliparous women using a Copper 7 intrauterine contraceptive device.Br. Med. J.,281, 14–15

    PubMed  Google Scholar 

  38. Centers for Disease Control, NDTI, NAMCS (1965–1981). Statistical services, Div. Venereal Disease Control. Total Visits for PID and Rates Per 100 000 Population for Age Groups 15–50 and with Women in Age-Groups 15–50. United States Calendar Years 1965–1981. (Unpublished data)

  39. LuukkainenT., NielsenN., NygrenK., PyöräläT. and AllonenH. (1979). Combined and national experience of postmenstrual IUD insertions of Nova-T and Copper-T in a randomized study.Contraception,19, 11–20

    PubMed  Google Scholar 

  40. O'BrienF. B., StewartW. C. and SturtevantF. M. (1983). Incidence of pelvic inflammatory disease in clinical trials with Cu-7 (intrauterine contraceptive device): a statistical analysis.Contraception,27, 111–122

    PubMed  Google Scholar 

  41. WeströmL. (1980). Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries.Am. J. Obstet. Gynecol.,138, 880–891

    PubMed  Google Scholar 

  42. Eschenbach, D. A. (1977). Epidemiology and diagnosis of acute pelvic inflammatory disease.Obstet. Gynecol.,55, 142S

    Google Scholar 

  43. WeströmL., BengtssonL. P. and MårdhP. (1976). The risk of pelvic inflammatory disease in women using intrauterine contraceptive devices as compared to non-users.Lancet,2, 221–224

    PubMed  Google Scholar 

  44. WrightN. H. and Combined Bangkok Hospital Group. (1975). Unsuspected pelvic infection discovered at tubal location: relationship to use of intrauterine contraception. In:Analysis of Intrauterine Conception, F.Hefnawi and S. J.Segal, eds., North Holland, Amsterdam, pp. 401–409

    Google Scholar 

  45. GumpD. W., GibsonM. and AshikagaT. (1983). Evidence of prior pelvic inflammatory disease and its relationship toChlamydia trachomatis antibody and IUD use in infertile women.Am. J. Obstet. Gynecol.,146, 153–159

    PubMed  Google Scholar 

  46. KaufmanD. W., WatsonJ., RosenbergS. P., MillerD. R., MeittinenO. S., StolleyP. D. and ShapiroS. (1983). The effect of different types of intrauterine devices on the risk of pelvic inflammatory disease.J. Am. Med. Assoc.,250, 759–762

    Google Scholar 

  47. SparksR. A., PurrierB. G., WattP. J. and ElsteinM. (1981). Bacteriological colonization of uterine cavity: role of tailed intrauterine contraceptive device.Br. Med. J.,282, 1189–1191

    Google Scholar 

  48. WrightN. H. and LaemmleP. (1968). Acute pelvic inflammatory disease in an indigent population.Am. J. Obstet. Gynecol.,101, 979–998

    PubMed  Google Scholar 

  49. LeeN. C., RubinC. L., OryH. W. and BurkmanR. T. (1983). Type of intrauterine device and the risk of pelvic inflammatory disease.Obstet. Gynecol.,62, 1–6

    PubMed  Google Scholar 

  50. VesseyM. P., YeatesD., FlavelR. and McPhersonK. (1981). Pelvic inflammatory disease and the intrauterine device: findings in a large cohort study.Br. Med. J.,1, 855–857

    Google Scholar 

  51. SnowdenR. and PearsonB. (1984). Pelvic infection-a comparison of the Dalkon Shield and three other intrauterine devices.Br. Med. J.,288, 1570

    Google Scholar 

  52. MacmahonB. and PughT. F. (1970).Epidemiology: Principles and Methods, Little, Brown & Co., Boston

    Google Scholar 

  53. HorwitzR. I. and FeinsteinA. R. (1979). Methodologic standards and contradictory results in case-control research.Am. J. Med.,66, 556–564

    PubMed  Google Scholar 

  54. BreslowN. E. and DayN. E. (1980).Statistical Methods in Cancer Research. Vol. 1:The Analysis of Case-Control Studies, IARC, Lyon

    Google Scholar 

  55. WeströmL. (1980). International forum.Int. J. Gynaecol. Obstet.,17, 509–511

    Google Scholar 

  56. TothA. (1983). Alternative causes of pelvic inflammatory disease.J. Repord. Med.,28, 699–702S

    Google Scholar 

  57. TothA., O'LearyW. M. and LedgerW. (1982). Evidence for microbial transfer by spermatozoa.Obstet. Gynecol.,59, 556–558

    PubMed  Google Scholar 

  58. WitkinS. S. and TothA. (1983). Relationship between genital tract infections, sperm antibodies in seminal fluid, and infertility.Fertil. Steril.,40, 805–808

    PubMed  Google Scholar 

  59. FribergJ. (1983). Sperm can be vector of germs that cause PID.Obstet. Gynecol. News,18, 3

    Google Scholar 

  60. Wølner-HanssenP. and MårdhP. A. (1984).In vitro tests of the adherence ofChlamydia trachomatis to human spermatozoa.Fertil. Steril.,42, 102

    PubMed  Google Scholar 

  61. Hafez, E. S. E. (1984). Microbiological contaminants of human semen used forin vitro fertilization: a possible etiology for idiopathic male infertility. Presented at 1st World. Conf. on Infectious Diseases & Human Fertility, 16th March, Lenox Hill Hospital, New York, NY

  62. FowlkesD. M., DooherG. B. and O'LearyW. M. (1975). Evidence by scanning electron microscopy for an association between spermatozoa and T-mycoplasmas in men of infertile marriage.Fertil. Steril.,26, 1203–1211

    PubMed  Google Scholar 

  63. James-HolmquistA. N., SwansonJ., BuchananT. M., WendeR. D. and WilliamsR. P. (1974). Differential attachment by piliated and nonpiliated gonorrhoeae to human sperm.Infect. Immun.,9, 897–902

    PubMed  Google Scholar 

  64. KelaghanJ., RubinG. L., OryH. W. and LaydeP. M. (1982). Barrier-method contraceptives and pelvic inflammatory disease.J. Am. Med. Assoc.,248, 184–187

    Google Scholar 

  65. RubinG. L., OryH. W. and LaydeP. M. (1982). Oral contraceptives and pelvic inflammatory disease.Am. J. Obstet. Gynecol.,144, 630–635

    PubMed  Google Scholar 

  66. ElsteinM. (1978). Functions and physical properties of mucus in the fernale genital tract.Br. Med. Bull.,34, 83–88

    PubMed  Google Scholar 

  67. TsibrisJ. C., ThomasonJ. L., KunigkA., Khan-DawoodF. S., KirschnerC. V. and SpellacyW. N. (1982). Guaiacol peroxidase levels in human cervical mucus: a possible predictor of ovulation.Contraception,25, 59–67

    PubMed  Google Scholar 

  68. TargumS. D. and WrightN. H. (1974). Association of the intrauterine device and pelvic inflammatory disease: a retrospective pilot study.Am. J. Epidemiol.,100, 262–271

    PubMed  Google Scholar 

  69. MishellD. R., BellJ. H., GoodR. G., and MoyerD. L. (1966). The intrauterine device: a bacteriologic study of the endometrial cavity.Am. J. Obstet. Gynecol.,96, 119–126

    PubMed  Google Scholar 

  70. MishellD. R. (1984). Putting a stop to salpingitis.Emer. Med.,16, 22

    Google Scholar 

  71. LippesJ. (1975). Infection and the IUD-a preliminary report.Contraception,12, 103–106

    PubMed  Google Scholar 

  72. RydenG., FahraeusL. and AhmanK. (1979). Do contraceptives influence the incidence of acute pelvic inflammatory disease in women with gonorrhea?Contraception,20, 149–157

    PubMed  Google Scholar 

  73. ThalerJ., PaldiE. and SteinerD. (1978). Intrauterine device and pelvic inflammatory disease.Int. J. Fertil.,23, 69–72

    PubMed  Google Scholar 

  74. GrahamS. and SimcockB. W. (1982). A review of the use of intrauterine devices in nulliparous women.Contraception,26, 323–346

    PubMed  Google Scholar 

  75. NygrenK. G., NielsenN. C., PyöräläT., AllonenH. and LuukkainenT. (1983). Nova-T: long-term effectiveness and clinical performance.Acta Obstet. Gynecol. Scand., Suppl.,116, 93

    Google Scholar 

  76. OsserS., LiedholmP., GullbergB. and SjöbergN. O. (1980). Risk of pelvic inflammatory disease among intrauterine device users irrespective of previous pregnancy.Lancet,1, 386–388

    PubMed  Google Scholar 

  77. WHO Task Force on Intrauterine Devices (1984). PID associated with fertility regulating agents.Contraception,30, 1–21

    Google Scholar 

  78. CunananR. G., CoureyN. G. and LippesJ. (1983). Laparoscopic findings in patients with pelvic pain.Am. J. Obstet. Gynecol.,146, 589–591

    PubMed  Google Scholar 

  79. ChatmanD. L. (1976). Endometriosis in the black woman.Am. J. Obstet. Gynecol.,125, 987–989

    PubMed  Google Scholar 

  80. SchachterJ. (1983). Chlamydia usually inapparent; presumptive indicators don't apply.Obstet. Gynecol. News,18(24), 45

    Google Scholar 

  81. SvenssonL., WeströmL. and MårdhP. A. (1984). Contraceptives and acute salpingitis.J. Am. Med. Assoc.,251, 2553

    Google Scholar 

  82. RosenfeldD. L., SeidmanS. M., BronsonS. M. and SchollG. M. (1983). Unsuspected chronic pelvic inflammatory disease in the infertile female.Fertil. Steril.,39, 44–48

    PubMed  Google Scholar 

  83. GibsonM., GumpD., AshikagaT. and HallB. (1984). Patterns of adnexal inflammatory damage: chlamydia, the intrauterine device, and history of pelvic inflammatory disease.Fertil. Steril.,41, 47

    PubMed  Google Scholar 

  84. EdwardsL. E., RastogiS. P., HurleyS. K. and HakansonE. Y. (1981). Intrauterine-device-related hospitalizations.Adv. Planned Parenthood,16, 65–70

    Google Scholar 

  85. TatumH. J., SchmidtF. H., PhillipsD., McCartyM. and O'LearyW. M. (1975). Dalkon Shield controversy-structural and bacteriological studies of IUD tails.J. Am. Med. Assoc.,231, 711–717.

    Google Scholar 

  86. PurrierB. G., SparksR. A., WattP. J. and ElsteinM. (1979).In vitro study of the possible role of the intrauterine tract.Br. J. Obstet. Gynaecol.,86, 374–378

    PubMed  Google Scholar 

  87. SkangalisM., MahoneyC. J. and O'LearyW. M. (1982). Microbial presence in the intrauterine cavity as affected by varieties of intrauterine contraceptive devices.Fertil. Steril.,37, 263–269

    PubMed  Google Scholar 

  88. Cole, L. P. (1984). IUDs With or Without Strings. Presented at the PARFR Workshop on Intrauterine Contraception: Advances and Future Prospects. Chicago, IL, May 29–June 1

  89. SpornitzU. M., MakabeS., HafezE. S. E. and vanOsW. A. A. (1984). IUD technology — scanning microscopy of the IUD tail.Contracept. Deliv. Syst.,5, 29–45

    PubMed  Google Scholar 

  90. Ory, H., Forrest, J. D. and Lincoln, R. (1983).Making Choices. Evaluating the Health Risks and Benefits of Birth Control Methods. The Guttmacher Institute, pp. 48–49

  91. WashingtonA. E., CatesW. and ZaidiO. A. (1984). Hospitalization for pelvic inflammatory disease.J. Am. Med. Assoc.,251, 2529

    Google Scholar 

  92. Centers for Disease Control (1984). Gonorrhea-United States, 1983.Morbid. Mortal. Weekly Rep.,33, 361–363

    Google Scholar 

  93. Weisner, P. J. (1980). Magnitude of the problem of sexually transmitted diseases in the United States. In:Sexually Transmitted Disease, 1980 Status Report. NIAID Study Group, NIH Publ. No. 81-2213, pp. 21–31

  94. CatesW. (1984). Sexually transmitted diseases: the national view.Cutis,33, 69–80

    PubMed  Google Scholar 

  95. AralS. O. and HolmesK. K. (1984). Epidemiology of sexually transmitted diseases. In:Sexually Transmitted Disease, K. K.Holmes, P. A.Mårdh, P. F.Sparling and P. J.Weisner, eds., McGraw-Hill, New York, pp. 126–141

    Google Scholar 

  96. AdlerM. W. (1983). ABC of sexually transmitted diseases: a changing and growing social problem.Br. Med. J.,287, 1279–1283

    Google Scholar 

Download references

Author information

Affiliations

  1. Associate Director, Scientific Affairs, G. D. Searle & Co., 60077, Skokie, IL, USA

    B. J. Struthers

Authors
  1. B. J. Struthers
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Struthers, B.J. Pelvic inflammatory disease, intrauterine contraception, and the conduct of epidemiologic studies. Adv Contracept 1, 63–76 (1985). https://doi.org/10.1007/BF01849145

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01849145

Keywords

  • Public Health
  • Epidemiologic Study
  • Socioeconomic Status
  • Inflammatory Disease
  • Sexual Partner